Sellas Life Sciences Stock Total Asset

SLS Stock

USD 1.66 0.07 4.40%

Fundamental analysis of Sellas Life allows traders to better anticipate movements in Sellas Life's stock price by examining its financial health and performance throughout various phases of its business cycle.

	Last Reported	Projected for Next Year
Total Assets	19.4 M	36.2 M
Intangibles To Total Assets	0.10	0.09

Total Assets is likely to gain to about 36.2 M in 2025, whereas Intangibles To Total Assets are likely to drop 0.09 in 2025.

Build AI portfolio with Sellas Stock

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sellas Life Sciences Company Total Asset Analysis

Sellas Life's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current Sellas Life Total Asset

19.43 M

Most of Sellas Life's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sellas Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Sellas Total Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Sellas Life is extremely important. It helps to project a fair market value of Sellas Stock properly, considering its historical fundamentals such as Total Asset. Since Sellas Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sellas Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sellas Life's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Total Current Assets	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Common Stock	Current Deferred Revenue	Short Term Debt	Net Tangible Assets	Good Will	Long Term Debt Total	Capital Surpluse	Intangible Assets	Property Plant Equipment	Long Term Debt	Deferred Long Term Liab	Net Receivables	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.61	-0.57	0.92	-0.48	-0.21	-0.36	0.9	0.8	0.66	0.44	0.05	0.62	0.7	0.73	0.77	-0.23	0.69	0.42	0.46	0.02	0.4	-0.28	-0.28
Total Stockholder Equity	0.61		-0.45	0.56	-0.28	-0.35	-0.2	0.21	0.49	0.24	0.3	0.74	0.37	0.16	0.55	0.45	-0.18	0.12	0.08	0.02	0.08	0.64	0.19	-0.21
Net Debt	-0.57	-0.45		-0.75	0.18	0.36	0.2	-0.46	-0.27	-0.27	0.34	-0.28	-0.24	-0.27	-0.26	-0.12	-0.27	-0.29	-0.15	-0.32	0.28	-0.47	-0.3	0.17
Total Current Assets	0.92	0.56	-0.75		-0.51	-0.26	-0.36	0.82	0.7	0.6	0.33	0.07	0.48	0.67	0.7	0.48	-0.02	0.71	0.43	0.52	0.13	0.49	-0.04	-0.25
Retained Earnings	-0.48	-0.28	0.18	-0.51		0.24	0.56	-0.42	-0.71	-0.46	-0.41	-0.09	-0.1	-0.7	-0.81	-0.24	-0.36	-0.72	0.03	-0.28	-0.62	0.19	0.03	-0.32
Accounts Payable	-0.21	-0.35	0.36	-0.26	0.24		-0.39	-0.07	-0.44	-0.14	0.09	-0.49	-0.59	-0.04	-0.44	-0.15	-0.08	-0.11	-0.43	-0.29	0.07	-0.15	0.06	0.04
Short Term Investments	-0.36	-0.2	0.2	-0.36	0.56	-0.39		-0.31	-0.26	-0.28	-0.23	0.06	0.41	-0.57	-0.33	-0.05	-0.19	-0.49	0.45	0.05	-0.46	0.1	-0.28	-0.17
Total Liab	0.9	0.21	-0.46	0.82	-0.42	-0.07	-0.31		0.72	0.69	0.39	-0.35	0.57	0.77	0.61	0.71	-0.21	0.77	0.5	0.56	-0.04	0.15	-0.47	-0.27
Common Stock	0.8	0.49	-0.27	0.7	-0.71	-0.44	-0.26	0.72		0.65	0.55	0.09	0.67	0.64	0.87	0.66	-0.24	0.69	0.5	0.51	0.28	0.05	-0.46	0.03
Current Deferred Revenue	0.66	0.24	-0.27	0.6	-0.46	-0.14	-0.28	0.69	0.65		0.24	-0.1	0.35	0.58	0.65	0.56	-0.2	0.8	0.2	0.82	0.15	0.13	-0.23	-0.18
Short Term Debt	0.44	0.3	0.34	0.33	-0.41	0.09	-0.23	0.39	0.55	0.24		-0.1	0.3	0.47	0.61	0.46	-0.43	0.39	0.37	0.05	0.61	0.12	-0.38	-0.22
Net Tangible Assets	0.05	0.74	-0.28	0.07	-0.09	-0.49	0.06	-0.35	0.09	-0.1	-0.1		0.11	-0.3	0.26	0.0	0.02	-0.31	-0.16	-0.16	-0.01	0.33	0.36	-0.14
Good Will	0.62	0.37	-0.24	0.48	-0.1	-0.59	0.41	0.57	0.67	0.35	0.3	0.11		0.16	0.48	0.7	-0.43	0.23	0.83	0.46	-0.3	0.22	-0.68	-0.34
Long Term Debt Total	0.7	0.16	-0.27	0.67	-0.7	-0.04	-0.57	0.77	0.64	0.58	0.47	-0.3	0.16		0.7	0.5	0.14	0.9	0.08	0.26	0.39	0.02	-0.1	0.04
Capital Surpluse	0.73	0.55	-0.26	0.7	-0.81	-0.44	-0.33	0.61	0.87	0.65	0.61	0.26	0.48	0.7		0.58	-0.05	0.72	0.31	0.44	0.47	0.12	-0.21	-0.16
Intangible Assets	0.77	0.45	-0.12	0.48	-0.24	-0.15	-0.05	0.71	0.66	0.56	0.46	0.0	0.7	0.5	0.58		-0.44	0.42	0.35	0.26	-0.24	0.18	-0.58	-0.37
Property Plant Equipment	-0.23	-0.18	-0.27	-0.02	-0.36	-0.08	-0.19	-0.21	-0.24	-0.2	-0.43	0.02	-0.43	0.14	-0.05	-0.44		0.11	-0.46	-0.15	0.14	-0.09	0.57	0.45
Long Term Debt	0.69	0.12	-0.29	0.71	-0.72	-0.11	-0.49	0.77	0.69	0.8	0.39	-0.31	0.23	0.9	0.72	0.42	0.11		0.17	0.61	0.44	0.03	-0.13	0.09
Deferred Long Term Liab	0.42	0.08	-0.15	0.43	0.03	-0.43	0.45	0.5	0.5	0.2	0.37	-0.16	0.83	0.08	0.31	0.35	-0.46	0.17		0.5	-0.1	0.21	-0.63	-0.38
Net Receivables	0.46	0.02	-0.32	0.52	-0.28	-0.29	0.05	0.56	0.51	0.82	0.05	-0.16	0.46	0.26	0.44	0.26	-0.15	0.61	0.5		0.04	0.11	-0.3	-0.19
Short Long Term Debt	0.02	0.08	0.28	0.13	-0.62	0.07	-0.46	-0.04	0.28	0.15	0.61	-0.01	-0.3	0.39	0.47	-0.24	0.14	0.44	-0.1	0.04		-0.08	0.22	0.27
Net Invested Capital	0.4	0.64	-0.47	0.49	0.19	-0.15	0.1	0.15	0.05	0.13	0.12	0.33	0.22	0.02	0.12	0.18	-0.09	0.03	0.21	0.11	-0.08		0.41	-0.36
Net Working Capital	-0.28	0.19	-0.3	-0.04	0.03	0.06	-0.28	-0.47	-0.46	-0.23	-0.38	0.36	-0.68	-0.1	-0.21	-0.58	0.57	-0.13	-0.63	-0.3	0.22	0.41		0.2
Capital Stock	-0.28	-0.21	0.17	-0.25	-0.32	0.04	-0.17	-0.27	0.03	-0.18	-0.22	-0.14	-0.34	0.04	-0.16	-0.37	0.45	0.09	-0.38	-0.19	0.27	-0.36	0.2

Click cells to compare fundamentals

Sellas Total Asset Historical Pattern

Today, most investors in Sellas Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sellas Life's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Sellas Life total asset as a starting point in their analysis.

Sellas Life Total Asset

Timeline

Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Competition

Predict Sellas Life

Total Assets Over Time

Sellas Total Assets

Total Assets

36.16 Million

At this time, Sellas Life's Total Assets are comparatively stable compared to the past year.

Based on the latest financial disclosure, Sellas Life Sciences has a Total Asset of 19.43 M. This is 99.74% lower than that of the Biotechnology sector and 99.02% lower than that of the Health Care industry. The total asset for all United States stocks is 99.93% higher than that of the company.

Sellas Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sellas Life's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sellas Life could also be used in its relative valuation, which is a method of valuing Sellas Life by comparing valuation metrics of similar companies.

Sellas Life is currently under evaluation in total asset category among its peers.

Sellas Life Current Valuation Drivers

We derive many important indicators used in calculating different scores of Sellas Life from analyzing Sellas Life's financial statements. These drivers represent accounts that assess Sellas Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sellas Life's important valuation drivers and their relationship over time.

	2020	2021	2022	2023	2024	2025 (projected)
Market Cap	417.1M	770.5M	412.0M	265.0M	636.5M	731.4M
Enterprise Value	382.8M	749.9M	395.8M	263.4M	623.5M	712.9M

Sellas Life Institutional Holders

Institutional Holdings refers to the ownership stake in Sellas Life that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sellas Life's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sellas Life's value.

		Shares
Atom Investors Lp	2025-03-31	64.2 K
Ubs Group Ag	2025-03-31	62.2 K
Jane Street Group Llc	2025-03-31	58.5 K
Virtu Financial Llc	2025-03-31	53.9 K
Mariner Wealth Advisors Llc	2025-03-31	51.2 K
Two Sigma Investments Llc	2025-03-31	48.3 K
Renaissance Technologies Corp	2025-03-31	34.9 K
Jain Global Llc	2025-03-31	27.4 K
Gsa Capital Partners Llp	2025-03-31	22.7 K
Anson Funds Management Lp	2025-03-31	7.6 M
Vanguard Group Inc	2025-03-31	2.8 M

Sellas Fundamentals

	Return On Equity	-1.45
	Return On Asset	-0.59
	Current Valuation	138.1 M
	Shares Outstanding	99.78 M
	Shares Owned By Insiders	0.33 %
	Shares Owned By Institutions	14.84 %
	Number Of Shares Shorted	27.74 M
	Price To Book	5.97 X
	Price To Sales	26.90 X
	Gross Profit	900 K
	EBITDA	(30.88 M)
	Net Income	(30.88 M)
	Cash And Equivalents	26.99 M
	Cash Per Share	1.31 X
	Total Debt	1 M
	Debt To Equity	0.06 %
	Current Ratio	2.36 X
	Book Value Per Share	0.30 X
	Cash Flow From Operations	(35.4 M)
	Short Ratio	6.95 X
	Earnings Per Share	(0.36) X
	Target Price	6.83
	Number Of Employees	15
	Beta	2.32
	Market Capitalization	158.65 M
	Total Asset	19.43 M
	Retained Earnings	(248.12 M)
	Working Capital	6.82 M
	Net Asset	19.43 M

About Sellas Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sellas Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sellas Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sellas Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC